guanfacine

Shire's INTUNIV (Guanfacine) extended release in children with ADHD and oppositional symptoms

...d as a once-daily, extended release formulation of guanfacine designed to provide steady delivery of drug throug... impulsivity. Although the mechanism of action of guanfacine in the treatment of ADHD is not fully understood, ...euronal firing. This research supports the use of guanfacine for the treatment of ADHD. In pivotal clinica...

Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18

...dimesylate (CII) and investigational non-scheduled guanfacine extended release, at a national scientific meeting.... "We believe the lisdexamfetamine dimesylate and guanfacine extended release study findings to be presented wi...ity Disorder Poster Presentation #NR2-038 guanfacine Extended Release May 18, 2009; 12:30 PM to 2:00...

Shire to present ADHD treatments scientific data at American Psychiatric Assoc. Meeting

...gational non-stimulant treatment under FDA review, guanfacine extended release, at the American Psychiatric Asso...dimesylate, methylphenidate transdermal system and guanfacine extended release study findings to be presented at...ls with ADHD APA Poster Presentation # NR6-018 guanfacine Extended Release: May 7, 2008; 12:00 p.m. ET ...

FDA Approves INTUNIV (guanfacine) for the Treatment of ADHD

...stration tolerance. The selective alpha-2A agonist strengthens working memory and prefrontal cortex neuronal firing. This research supports the use of guanfacine for the treatment of ADHD. ...

New Light on Working of Brain Networks

...rd from the Kavli Institute of Neuroscience at Yale. Arnsten and Yale have a license agreement with Shire Pharmaceuticals for the development of guanfacine for the treatment of patients with ADHD. Yale has submitted a patent application on the use of HCN blockers for the treatment of PFC cognitive deficit...

Brain Networks Strengthened by Closing Ion Channels

...ward from the Kavli Institute of Neuroscience at Yale. Arnsten and Yale have a license agreement with Shire Pharmaceuticals for the development of guanfacine for the treatment of patients with ADHD. Yale has submitted a patent application on the use of HCN blockers for the treatment of PFC cognitive deficit...

Common PTSD Drug is No More Effective Than Placebo

... The double-blind study compared the effects of guanfacine and an identical looking placebo pill on 63 male a...eeks. At the end of the study, the effect of guanfacine on PTSD symptoms was “zero,” and there were no dif...unger veterans. In addition, the subjects who took guanfacine had significantly more somnolence, lightheadedness...

Clinical Comparisons Between ADHD Drugs Are Less

...ulant drugs such as Strattera (atomoxetine), antihypertensive drugs such as guanfacine and older antipsychotic drugs such as clozapine. Limited evidence suggests that the antihypertensive drugs clonidine and guanfacine reduce the severity of facial tics in children with ADHD, but the two drugs...

guanfacine in Medical Technology

FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents

...control.(6-10) Although the mechanism of action of guanfacine in the treatment of ADHD is not fully understood, ...ronal firing.(6) This research supports the use of guanfacine for the treatment of ADHD.(6) Safety was al...domized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with ...

Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms

...d as a once-daily, extended release formulation of guanfacine designed to provide steady delivery of drug throug... impulsivity. Although the mechanism of action of guanfacine in the treatment of ADHD is not fully understood, ...euronal firing. This research supports the use of guanfacine for the treatment of ADHD. In pivotal clini...

Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose

...stration tolerance. The selective alpha-2A agonist strengthens working memory and prefrontal cortex neuronal firing. This research supports the use of guanfacine for the treatment of ADHD. Safety data showed that adverse events reported by participants using INTUNIV were generally mild to moderate in severity...

Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting

...gational non-stimulant treatment under FDA review, guanfacine extended release, at the American Psychiatric Asso...dimesylate, methylphenidate transdermal system and guanfacine extended release study findings to be presented at...rls with ADHD APA Poster Presentation # NR6-018 guanfacine Extended Release: May 7, 2008; 12:00 p.m. ET ...

Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting

...ion- Deficit/Hyperactivity Disorder APA Poster# NR659 May 23, 2007; 12:00 p.m. PDT (3:00 p.m. EDT) Long-Term, Open-Label Study of guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder APA Poster# NR658 About VYVANSE and ADDERALL ...

Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents

...sults of studies of the investigational medication guanfacine extended release (GXR, previously referred to as S...-21.6 points from baseline to endpoint (P About guanfacine Extended Release Shire is seeking approval of GX...hyperactive/impulsive and inattentive subscales. guanfacine extended release is a once-daily formulation of a ...